Investing in the emerging cannabis industry worldwide

Opportunity knows no borders. We invest in the most attractive and defensible points in the value chain of global cannabis. North America and Europe are the leading consumer markets for medical cannabis. Equatorial low-cost cultivation. Research and technology in Israel. We invest where the opportunity is greatest, where the risk is balanced, and where the outcomes for value creation are most favorable.

Branded Product

identity and relationship with the consumer

The push model of today will be the pull model tomorrow. Consumer and patient connection will guide future shelf space decisions.

Distribution and Commerce

supply chain control

Own the channels, own the market. Defensible distribution plays will dictate commerce and controls.

Genetics

QUALITY AND EFFICACY IN DNA SELECTION

Plant breeding and genetic discovery will herald in new strains, drive cannabinoid expression, and micropropagation will be the future of cultivation.

Technology

Innovation and vision

New distribution methods, consumer and provider apps, and disruptive, online markets. Seamlessly reduce friction and pain across industry sectors.

LONDON | SAN JOSE